NC-R17
NC-R17 is a PROTAC-class, non-covalent GPX4 degrader based on RSL3, involved in ferroptosis. NC-R17 has antitumor activity and is used for non-covalent GPX4 PROTAC design[1]. NC-R17 consists of a target protein ligand (red part) Demethyl-RSL3 ; an E3 ubiquitin ligase ligand (blue part) Lenalidomide (HY-A0003) and a PROTAC linker (black part) (HY-169376). E3 ubiquitin ligase and linker can form Lenalidomide-C13-piperazine-Boc (HY-169377)[2].
Product Specifications
CAS Number
3049087-34-2
UNSPSC
12352005
Target
Ferroptosis; Glutathione Peroxidase; PROTACs
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nc-r17.html
Solubility
10 mM in DMSO
Smiles
O=C(OC)[C@@H]1N(C(CC)=O)[C@@H](C2=CC=C(C(N3CCN(CCCCCCCCCCCCCNC4=C(CN(C5C(NC(CC5)=O)=O)C6=O)C6=CC=C4)CC3)=O)C=C2)C7=C(C(C=CC=C8)=C8N7)C1
Molecular Formula
C53H67N7O7
Molecular Weight
914.14
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GPX4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Claudin 22 (CLDN22) Human Gene Knockout Kit (CRISPR)
Human TGF beta induced factor 2 (TGIF2) activation kit by CRISPRa
![DNAJC15 Recombinant Rabbit Monoclonal Antibody [SY26-04]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea81a9c/imageurl/et1607-52.webp)